Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/18719
Title: A systematic review of dapagliflozin treatment for patients with type 2 diabetes mellitus
Authors: El-Hayek, Mohamad
Keywords: dapagliflozin
type 2 diabetes mellitus
Issue Date: 2017
Citation: El-Hayek M. A systematic review of dapagliflozin treatment for patients with type 2 diabetes mellitus / M. El-Hayek // Xth International Scientific Interdisciplinary Conference (ISIC) for medical students and young scientists, Ukraine, 24–26 may 2017 : abstract book. – Kharkiv : KhNMU, 2017. – P. 36.
Abstract: New class of drugs for treatment type 2 diabetes mellitus (T2DM) are sodium-glucose cotransporter 2 (SGLT2) inhibitors. These drug are an antihyperglycaemic agents with an insulin-independent mode of action. One of the SGLT2 inhibitors class that used in Ukraine for treatment patients with T2DM is a Dapagliflozin. We try to summarize current evidence from different clinical trials that assess the clinical efficacy and safety of dapagliflozin.
URI: http://repo.knmu.edu.ua/handle/123456789/18719
Appears in Collections:Наукові роботи молодих вчених. Кафедра внутрішньої медицини № 3 та ендокринології

Files in This Item:
File Description SizeFormat 
A systematic .pdf249,57 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.